Literature DB >> 10965979

Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle.

T Namekata1, K Miki, M Kimmey, T Fritsche, D Hughes, D Moore, K Suzuki.   

Abstract

Gastric cancer is still a major cause of mortality due to cancer worldwide. The most common type of gastric cancer is intestinal type carcinoma, which usually occurs in stomachs containing chronic atrophic gastritis. Individuals with chronic atrophic gastritis are considered to be at increased risk for developing intestinal type carcinoma of the stomach. To examine the association between chronic atrophic gastritis and other gastric cancer risk factors, a cross-sectional study was conducted using serum samples and questionnaire information collected from 776 persons of full Japanese ancestry in the greater Seattle area in 1994. The presence of chronic atrophic gastritis and Helicobacter pylori infection was determined by measurement of serum pepsinogen levels and H. pylori antibodies, respectively. Based on multiple logistic regression, the significant predictors of chronic atrophic gastritis were age over 50 years, H. pylori infection, and 20 years or more lived in Japan. Alcohol consumption, smoking, prior peptic ulcer, and history of gastric cancer in parents were not significantly associated with chronic atrophic gastritis. The results imply that H. pylori infection since earlier life and other unknown exposure factors in Japan might have played an important role in the development of chronic atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965979     DOI: 10.1093/oxfordjournals.aje.a010282

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

Review 2.  The dynamics of gastritis.

Authors:  E J Kuipers; T A Grool
Journal:  Curr Gastroenterol Rep       Date:  2001-12

3.  The time to eradicate gastric cancer is now.

Authors:  D Y Graham; A Shiotani
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

5.  Community-based familial study of Helicobacter pylori infection among healthy Japanese Brazilians.

Authors:  Lucy S Ito; Sueli M Oba-Shinjo; Samuel K Shinjo; Miyuki Uno; Suely K N Marie; Nobuyuki Hamajima
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.

Authors: 
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

8.  Seroprevalences ofHelicobacter pylori infection and chronic atrophic gastritis in the united Republic of Tanzania and the Dominican Republic.

Authors:  Kazuo Aoki; Paul E Kihaile; Mercedes Castro; Mildre Disla; Thomas B Nyambo; Junichi Misumi
Journal:  Environ Health Prev Med       Date:  2004-07       Impact factor: 3.674

9.  The effect of serum carotenoids on atrophic gastritis among the inhabitants of a rural area in Hokkaido, Japan.

Authors:  Y Ito; K Suzuki
Journal:  Environ Health Prev Med       Date:  2001-10       Impact factor: 3.674

Review 10.  Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.

Authors:  Shailja C Shah; Andrew Canakis; Richard M Peek; Monica Saumoy
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-21       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.